The ageing population and increased demand for healthcare products and services across the globe are creating great opportunities for businesses in the health and social care, medical devices, life sciences, bioscience and pharmaceutical markets. At the same time the delivery of global healthcare is changing fast and creating significant opportunities for private providers.

At Clearwater International we have the knowledge, experience, track record and reach to help companies exploit these growing global opportunities. Given these dynamics it’s a market which remains a rich source of M&A deal flow and corporate activity as private providers take advantage of outsourcing opportunities and investors seek to consolidate market positions. Our sector team works closely with innovative companies who are at the forefront of the healthcare revolution, advising businesses on their strategies for dealing with governments seeking to drive efficiencies and improve patient experiences.


Sector Comments

Healthcare Sector Comment – January 2017

As a new year rolls in and people adopt resolutions to be healthier and exercise more, vitamins, minerals and supplements (VMS) are flying off the shelves. Driven by increased take-up of sport and growing demand for natural ingredients, the market … Find out more…

Healthcare Sector Comment – December 2016

Transaction activity is booming in the elderly residential care market. This is being driven on by the availability of cheap debt, an increasingly ageing population, rising demand for specialist care for conditions such as dementia, and reablement care. In the … Find out more…

Healthcare Sector Comment – November 2016

On 9th November 2016, Donald Trump became the 45th US President-Elect, so what does this mean for the healthcare M&A market? First, during campaigning Trump promised to cut down on tax inversion M&A, which avoids US corporate taxes on foreign … Find out more…